期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

降压药物治疗对纤溶功能的影响

Effects of Antihypertensive Therapy on Fibrinolytic Function
下载PDF
导出
摘要 组织型纤溶酶原激活物 (t PA)及其抑制剂 1(PAI 1)的动态平衡决定了纤溶功能 ,高血压患者多存在纤溶功能减低 ,临床常用的六类降压药物对血浆t PA和PAI 1水平有着不同的影响。
作者 郭倩玉 王佩显
机构地区 天津市第一中心医院心内科 天津医科大学总医院心内科
出处 《心血管病学进展》 CAS 2004年第3期168-171,共4页 Advances in Cardiovascular Diseases
关键词 降压药物 治疗 纤溶功能 组织型纤溶酶原激活物 高血压
分类号 R544.1 [医药卫生—心血管疾病]
  • 相关文献

参考文献35

  • 1牛凤珍,吴炎,赵智斌,谢淑英,张锐,高嵩.氯沙坦降压疗效及对血管活性物质的影响[J].高血压杂志,2000,8(1):43-44. 被引量：8
  • 2王志坚,赵水平.心力衰竭患者纤溶参数变化及药物干预效果的评价[J].中国循环杂志,2002,17(1):38-40. 被引量：13
  • 3Goodfield NER,Newby DE,Ludiam CA,et al.Effects of acute angiotensin II type receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure[J].Circulation,1999,99:2983-2985.
  • 4Minai K,Matsumoto T,Horie H,et al.Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin converting enzyme inhibitors[J].J Am Coll Cardiol,2001,37:1565-1570.
  • 5Li SH,Beevers DG,Lip GY.Effects of antihypertensive therapy using enapril or lasartan on haemostatic markers in essential hypertension: a pilot prospective randomised double-blind parallel group trial[J].Int J Cardiol,2001,78(3): 241-246.
  • 6Brown NJ,Agirbasli M,Vaughan DE.Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans[J].Hypertension,1999,34:385-290.
  • 7Ranieri G,Filitti V,Andriani A,et al.Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertensive with or without other risk factors[J].Cardiovasc Drugs Ther,1996,10:119-123.
  • 8Ahaneku JE,Sakata K,Urano T,et al.Influence of baseline values on lipids,lipoproteins and fibrinolytic parameters during amlodipine treatment of hypertension in Japanese patients[J].Pharmacol Res,2000,41(1): 75-79.
  • 9Sakata K,Shiotani M,Yoshida H,et al.Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension[J].Am Heart J,1999,137:1094-1099.
  • 10Zehetgruber M,Beckmann R,Gabriel H,et al.The ACE-inhibitor lisinopril affects plasma insulin levels but not fibrinolytic parameters[J].Thromb Res,1996,83(2):143-152.

二级参考文献11

  • 1[1]Catherin L,David E,Newby,et al.Fibrinolytic actions of intra-arterial angiotensin Ⅱ and bradykinin in vivo in man.Cardiov Res,2000,47:707-714.
  • 2[2]Douglas E,Vaughan jean L,Gean L,et al.Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction.Circulation, 1997,96:442-447.
  • 3[3]Chritopher R,Gibbs M,Andrew D,et al.Abnormalities of hemorheological endothelial and pulatelet in patients with chronic heart failure in sinus rhythm,Effects of angiotensin-converting enzyme inhibit and β-blocker therapy.Circulation,2001,103:1746-1751.
  • 4[4]Nicholas ER,Goodfield MB,David E,et al.Effect of acute angiotensin Ⅱ type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patient with heart failure.Circulation,1999,99:2983-2985.
  • 5[5]Douglas E,Vaughan S,Lazos,et al.Angiotensin Ⅱ regulates the rexpression of plasminogen activator inhibitor-1 in cultured endothelial cell.J Clin Invest,1995,95:995-1001.
  • 6[6]Ridker P,Cynthia L,Gaboury,et al.Stimulation of plasminogen activator inhinbitor in vivo by the fusion of angiotensin Ⅱ,Evidence of a potential interaction between the rennin-angiotensin system and fibrinolytic function.Circulation,1993,87:1969-1973.
  • 7[7]Nancy J,Brown MD,James V,et al.Bradykinin stimulates tissue plasminogen activator release from human forearm vasculatue through B2 recepto-dependent,NO synthase-independnt and cyclooxygenase-independent pathway.Circulation, 2000,102:2190-2196.
  • 8Loa L,Wagstaff J,Autona.Losartan potassium a review of itsphamacology,Clinical efficacy and tolerability in the managementof hypertension[].Drugs.1995
  • 9Stearns RA,Miller RR,Doss GA,et al.The metabolism of Dup753a nonpeptide angiotensin II receptor antagonist, by rat, monkeyand human liver slices[].Drug Metabolism and Disposition.1991
  • 10Othawa M,Takayama F,Saitoh K.Pharmacokinetics and biochem-ical efficacy after single and multiple oral administration of losartan,an orally active nonpeptide angiotensin II receptor antagonist[].Br J Clin Pharmacol.

共引文献19

心血管病学进展
2004年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部